INTI
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jul 22 closing price
Capitalization
9.43M
IVEVF
Price
$2.28
Change
-$1.36 (-37.36%)
Updated
Feb 12 closing price
Capitalization
448.66M
Interact to see
Advertisement

INTI vs IVEVF

Header iconINTI vs IVEVF Comparison
Open Charts INTI vs IVEVFBanner chart's image
Inhibitor Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$7K
Capitalization9.43M
INVENTIVA SA
Price$2.28
Change-$1.36 (-37.36%)
Volume$1K
Capitalization448.66M
INTI vs IVEVF Comparison Chart in %
Loading...
INTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INTI vs. IVEVF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INTI is a Buy and IVEVF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (INTI: $0.05 vs. IVEVF: $2.28)
Brand notoriety: INTI and IVEVF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INTI: 42% vs. IVEVF: 100%
Market capitalization -- INTI: $9.43M vs. IVEVF: $448.66M
INTI [@Biotechnology] is valued at $9.43M. IVEVF’s [@Biotechnology] market capitalization is $448.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INTI’s FA Score shows that 0 FA rating(s) are green whileIVEVF’s FA Score has 0 green FA rating(s).

  • INTI’s FA Score: 0 green, 5 red.
  • IVEVF’s FA Score: 0 green, 5 red.
According to our system of comparison, IVEVF is a better buy in the long-term than INTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INTI’s TA Score shows that 4 TA indicator(s) are bullish.

  • INTI’s TA Score: 4 bullish, 3 bearish.

Price Growth

INTI (@Biotechnology) experienced а +13.96% price change this week, while IVEVF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVEVF($449M) has a higher market cap than INTI($9.43M). INTI YTD gains are higher at: -8.985 vs. IVEVF (-37.363).
INTIIVEVFINTI / IVEVF
Capitalization9.43M449M2%
EBITDA-3.56MN/A-
Gain YTD-8.985-37.36324%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash4.32MN/A-
Total Debt84.3KN/A-
FUNDAMENTALS RATINGS
INTI: Fundamental Ratings
INTI
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INTIIVEVF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
13%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
13%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 28 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEEAX10.640.05
+0.47%
RBC Small Cap Core A
PMJPX10.950.05
+0.46%
PIMCO RAE US Small I-2
PMICX10.950.02
+0.18%
Putnam Multi-Asset Income C
GPTUX13.580.02
+0.17%
GuidePath® Tactical Allocation Svc
HSWRX20.75-0.05
-0.24%
Hartford Schroders International Stk R3

INTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, INTI has been loosely correlated with TENX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INTI jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTI
1D Price
Change %
INTI100%
N/A
TENX - INTI
44%
Loosely correlated
-0.98%
BCDA - INTI
35%
Loosely correlated
+1.73%
ASPHF - INTI
24%
Poorly correlated
N/A
IVEVF - INTI
17%
Poorly correlated
N/A
IDRSF - INTI
6%
Poorly correlated
N/A
More

IVEVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVEVF has been loosely correlated with TRDA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if IVEVF jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVEVF
1D Price
Change %
IVEVF100%
N/A
TRDA - IVEVF
47%
Loosely correlated
+2.35%
MBCOF - IVEVF
32%
Poorly correlated
+1.90%
EPRX - IVEVF
28%
Poorly correlated
-0.90%
ATHE - IVEVF
25%
Poorly correlated
+15.32%
IDRSF - IVEVF
20%
Poorly correlated
N/A
More